Secondary prevention of stroke in the elderly: A review of the evidence

American Journal Geriatric Pharmacotherapy

Volumn 9, Issue 3, 2011, Pages 143-152

  Alhusban, Ahmed ^a,b   Fagan, Susan C ^a,b,c  

^a UNIVERSITY OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

blood pressure; elderly; secondary prevention; stroke; warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CANDESARTAN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; EPROSARTAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; NITRENDIPINE; PERINDOPRIL; RAMIPRIL; SIMVASTATIN; TELMISARTAN; THIAZIDE DIURETIC AGENT; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CHOLESTEROL BLOOD LEVEL; CLINICAL RESEARCH; CONTROLLED DRUG RELEASE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG UTILIZATION; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; GASTROINTESTINAL SYMPTOM; GERIATRIC CARE; GERIATRIC PATIENT; HEADACHE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; LIVER DISEASE; MEDICAL HISTORY; MEDICAL LITERATURE; MONOTHERAPY; MUSCLE DISEASE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK REDUCTION; SECONDARY PREVENTION; STROKE; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; UNSPECIFIED SIDE EFFECT;

EID: 79957994598     PISSN: 15435946     EISSN: 18767761     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2011.04.002     Document Type: Review

References (54)

1. L. Castilla-Guerra, M. del C. Fernandez-Moreno, and J. Alvarez-Suero Secondary stroke prevention in the elderly: new evidence in hypertension and hyperlipidemia Eur J Intern Med 20 2009 586 590
2. J. Sivenius, L. Cunha, and H.C. Diener Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age. ESPS2 Working Group Acta Neurol Scand 99 1999 54 60 (Pubitemid 29012618)
3. A.G. Rudd, A. Hoffman, and C. Down Access to stroke care in England, Wales and Northern Ireland: the effect of age, gender and weekend admission Age Ageing 36 2007 247 255 (Pubitemid 47072316)
4. R. Raine, W. Wong, and G. Ambler Sociodemographic variations in the contribution of secondary drug prevention to stroke survival at middle and older ages: cohort study BMJ 338 2009 b1279
5. Y.Y. Kee, W. Brooks, and A. Bhalla Do older patients receive adequate stroke care? An experience of a neurovascular clinic Postgrad Med J 85 2009 115 118
6. J.S. Ross, E.A. Halm, and D.M. Bravata Use of stroke secondary prevention services: are there disparities in care? Stroke 40 2009 1811 1819
7. G. Saposnik, S.E. Black, A. Hakim Investigators of the Registry of the Canadian Stroke Network (RCSN), Stroke Outcomes Research Canada (SORCan) Working Group Age disparities in stroke quality of care and delivery of health services Stroke 40 2009 3328 3335
8. S.C. Fagan, and D.C. Hess Stroke J. DiPiro, R. Talbert, G. Yee, Pharmacotherapy: a Pathophysiologic Approach 2008 McGraw-Hill New York
9. A. Algra, and J. van Gijn Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia J Neurol Neurosurg Psychiatry 60 1996 197 199 (Pubitemid 26044196)
10. C. Warlow Secondary prevention of stroke Lancet 339 1992 724 727
11. K.L. Furie, S.E. Kasner, and R.J. Adams Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack A guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 42 2011 227 276
12. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
13. The European Stroke Prevention Study (ESPS) Principal end-points The ESPS Group Lancet 2 1987 1351 1354
14. H.C. Diener, L. Cunha, and C. Forbes European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke J Neurol Sci 143 1996 1 13 (Pubitemid 26402780)
15. P.H. Halkes, J. van Gijn ESPRIT Study Group Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial [published correction appears in Lancet. 2007;369:274] Lancet 367 2006 1665 1673
16. A randomisedblinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) CAPRIE Steering Committee Lancet 348 1996 1329 1339
17. H.C. Diener, R.L. Sacco, S. Yusuf Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study [published correction appears in Lancet Neurol. 2008;7:985] Lancet Neurol 7 2008 875 884
18. R.L. Sacco, H.C. Diener, and S. Yusuf Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke N Engl J Med 359 2008 1238 1251
19. R.G. Hart, J.L. Halperin, L.A. Pearce Stroke Prevention in Atrial Fibrillation Investigators Lessons from the Stroke Prevention in Atrial Fibrillation trials Ann Intern Med 138 2003 831 838 (Pubitemid 38124645)
20. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group Ann Neurol 42 1997 857 865
21. Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study The Stroke Prevention in Atrial Fibrillation Investigators Stroke 21 1990 538 545
22. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation Analysis of pooled data from five randomized controlled trials [published correction appears in Arch Intern Med. 1994;154:2254] Arch Intern Med 154 1994 1449 1457
23. J. Mant, F.D. Hobbs, K. Fletcher BAFTA investigators Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 2007 493 503 (Pubitemid 47212371)
24. A. Rash, T. Downes, and R. Portner A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO) Age Ageing 36 2007 151 156 (Pubitemid 46455393)
25. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke EAFT (European Atrial Fibrillation Trial) Study Group Lancet 342 1993 1255 1262
26. W.R. Lewis, G.C. Fonarow, and K.A. LaBresh Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation Am J Cardiol 103 2009 227 231
27. S. Luders Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options Drugs 67 2007 955 963 (Pubitemid 46745239)
28. D. Lloyd-Jones, R.J. Adams, and T.M. Brown Heart disease and stroke statistics2010 update: a report from the American Heart Association Circulation 121 2010 e46 e215
29. J. Schrader, S. Luders, and A. Kulschewski Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES) Stroke 36 2005 1218 1226
30. PROGRESS Collaborative Group Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack Lancet 358 2001 1033 1041
31. N.S. Beckett, R. Peters, A.E. Fletcher HYVET Study Group Treatment of hypertension in patients 80 years of age or older N Engl J Med 358 2008 1887 1898 (Pubitemid 351620109)
32. A. Rodgers, S. MacMahon, and G. Gamble Blood pressure and risk of stroke in patients with cerebrovascular disease The United Kingdom Transient Ischaemic Attack Collaborative Group BMJ 313 1996 147 (Pubitemid 26238034)
33. S. Yusuf, P. Sleight, and J. Pogue Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
34. J. Schrader, S. Luders, A. Kulschewski Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors Stroke 34 2003 1699 1703 (Pubitemid 36842630)
35. E.C. Sandset, P.M.W. Bath, G. Boysen SCAST Study Group The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial Lancet 377 2011 741 750
36. W. Kozak, A. Kozak, and M.H. Johnson Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response study J Pharmacol Exp Ther 326 2008 773 782
37. B. Dahlof, R.B. Devereux, and S.E. Kjeldsen Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 2002 995 1003 (Pubitemid 34286536)
38. S. Yusuf, H.C. Diener, R.L. Sacco PRoFESS Study Group Telmisartan to prevent recurrent stroke and cardiovascular events N Engl J Med 359 2008 1225 1237
39. H. Arima, J. Chalmers, M. Woodward PROGRESS Collaborative Group Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial J Hypertens 24 2006 1201 1208 (Pubitemid 43772329)
40. A. Rodgers, N. Chapman, M. Woodward Perindopril Protection against Recurrent Stroke Study Collaborative Group Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region J Hypertens 22 2004 653 659 (Pubitemid 38368501)
41. R. Collins, J. Armitage, S. Parish Heart protection Study Collaborative Group Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions Lancet 363 2004 757 767
42. C. Iribarren, D.M. Reed, C.M. Burchfiel, and J.H. Dwyer Serum total cholesterol and mortality Confounding factors and risk modification in Japanese-American men JAMA 273 1995 1926 1932
43. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
44. P. Amarenco, J. Bogousslavsky, A. Callahan 3rd Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators High-dose atorvastatin after stroke or transient ischemic attack N Engl J Med 355 2006 549 559 (Pubitemid 44202151)
45. S. Chaturvedi, J. Zivin, A. Breazna SPARCL Investigators Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack Neurology 72 2009 688 694
46. J. Afilalo, G. Duque, and R. Steele Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis J Am Coll Cardiol 51 2008 37 45
47. T.J. Wilt, H.E. Bloomfield, and R. MacDonald Effectiveness of statin therapy in adults with coronary heart disease Arch Intern Med 164 2004 1427 1436 (Pubitemid 38937854)
48. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis North American Symptomatic Carotid Endarterectomy Trial Collaborators N Engl J Med 325 1991 445 453
49. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (7099%) or with mild (029%) carotid stenosis European Carotid Surgery Trialists' Collaborative Group Lancet 337 1991 1235 1243
50. Clinical alert: benefit of carotid endarterectomy for patients with high-grade stenosis of the internal carotid artery. National Institute of Neurological Disorders and Stroke Stroke and Trauma Division. North American Symptomatic Carotid Endarterectomy Trial (NASCET) investigators Stroke 22 1991 816 817
51. H.J. Barnett, D.W. Taylor, and M. Eliasziw Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis North American Symptomatic Carotid Endarterectomy Trial Collaborators N Engl J Med 339 1998 1415 1425 (Pubitemid 28516064)
52. T. Bonamigo, M. Lucas, and F. Pivatto Jr Results of carotid endarterectomy in octogenarians: a 10-years personal experience [in Portuguese] Rev Port Cir Cardiotorac Vasc 16 2009 83 89
53. A. Suliman, J. Greenberg, and A. Chandra Carotid endarterectomy as the criterion standard in high-risk elderly patients Arch Surg 143 2008 736 742 discussion 742
54. Change to: Brott TG, Hobson RW, Howard G, et al. Stenting versus endarterectomy for treatment of carotid artery stenosis. N Engl J Med 2010;363:1123.